ISGF3 Transcription Factor Family in Cytokine Signaling
细胞因子信号转导中的 ISGF3 转录因子家族
基本信息
- 批准号:7758248
- 负责人:
- 金额:$ 61.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1990
- 资助国家:美国
- 起止时间:1990-01-01 至 2012-01-31
- 项目状态:已结题
- 来源:
- 关键词:AchievementAnimal Cancer ModelAnimalsAntibodiesBindingBiochemicalBiologicalBiological ProcessBiologyC-terminalCancer BiologyCell CycleCellsCellular biologyCharacteristicsCollectionCompetenceComplexCytokine SignalingCytoplasmDataDevelopmentDiagnosisDimerizationDiseaseDrug Delivery SystemsEmbryonic DevelopmentFamilyFamily memberFutureGene ExpressionGeneticGenetic TranscriptionGoalsImmuneInflammatory ResponseMaintenanceMalignant - descriptorMalignant NeoplasmsMediatingModelingMolecularMotivationNormal CellNuclear TranslocationOncogene ProteinsPathway interactionsPlayProcessProteinsRegulationResearchResourcesRoleSTAT proteinSTAT1 geneSTAT3 geneSignal TransductionStem cellsStimulusTherapeuticTransactivationTransducersTumor Suppressor ProteinsTyrosineTyrosine Phosphorylationactivating transcription factoranimal tissuebaseextracellulargenetic regulatory proteinhuman diseaseinterferon-stimulated gene factor 3mutantnovelnovel strategiessrc Homology Region 2 Domaintooltrophoblasttumortumor progression
项目摘要
Signal Transducers and Activators of Transcription (STAT) proteins were originally characterized as
latent transcription factors activated by signal-dependent tyrosine phosphorylation. Two founding members
of this family, STAT1 and STATS, interact genetically and biochemically and have been shown to function in
innate immune and inflammatory responses. Recent evidence also shows that STAT1 has characteristics of
a tumor suppressor and STAT3 has characteristics of an oncogene, and these proteins play important but as
yet poorly understood roles in cancer progression.
A large body of research has fleshed out details of the JAK-STAT pathway, demonstrating the
importance of tyrosine phosphorylation, dimerization, nuclear translocation, DMA binding, and transcription
induction, features that fit the originally postulated role of STAT proteins as direct transducers of extracellular
signals. While this paradigm has served to explain many aspects of STAT function, emerging data suggest
that some biological functions of STAT1 and 3 are independent of one or more of the cornerstones of the
canonical pathway.We proopse to explore the molecular mechanisms and biological consequences of
STAT-dependent processes that are not fully explained by current models of JAK-STAT signaling.
We propose to pursue the following specific aims:
1. Characterize the essential role of STATS in trophectoderm function and embryonic development.
2. Characterize the role of STATS in Ras-induced cancer.
3. Characterize the regulation, interaction, and function of STAT1 and STATS during the cell cycle.
This research will be facilitated by our extensive collection of genetic and biochemical resources,
including single and double mutant cells and animals, tissue-specific mutant animals, animal models of
cancer, and antibody and molecular tools specific for STAT proteins. Achievement of the goals of this
proposal will increase our understanding of the complex roles of these proteins in normal biology and cancer,
will bridge a major gap in our current understanding of the mechanisms of STAT function, will further our
efforts towards optimization of therapeutic strategies targeting STATS,and will facilitate development of
novel strategies for better diagnosis and treatment of human disease.
信号转导和转录激活因子(STAT)蛋白最初被描述为
项目成果
期刊论文数量(58)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Rapid activation of proteins that interact with the interferon gamma activation site in response to multiple cytokines
响应多种细胞因子,快速激活与干扰素γ激活位点相互作用的蛋白质
- DOI:
- 发表时间:1994
- 期刊:
- 影响因子:0
- 作者:P. Lamb;L. Kessler;C. Suto;D. Levy;H. Seidel;R. Stein;J. Rosen
- 通讯作者:J. Rosen
Constitutive type I interferon modulates homeostatic balance through tonic signaling.
- DOI:10.1016/j.immuni.2012.01.011
- 发表时间:2012-02-24
- 期刊:
- 影响因子:32.4
- 作者:Gough DJ;Messina NL;Clarke CJ;Johnstone RW;Levy DE
- 通讯作者:Levy DE
Differential regulation of constitutive major histocompatibility complex class I expression in T and B lymphocytes.
组成型主要组织相容性复合物I类表达的差异调节。
- DOI:10.1084/jem.190.10.1451
- 发表时间:1999-11-15
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
IL-21 mediates suppressive effects via its induction of IL-10.
- DOI:10.4049/jimmunol.0802978
- 发表时间:2009-03-01
- 期刊:
- 影响因子:0
- 作者:Spolski R;Kim HP;Zhu W;Levy DE;Leonard WJ
- 通讯作者:Leonard WJ
Restricted tissue tropism and acquired resistance to Sindbis viral vector expression in the absence of innate and adaptive immunity.
在缺乏先天性和适应性免疫的情况下,组织向性受到限制并获得了对辛德比斯病毒载体表达的抗性。
- DOI:10.1038/sj.gt.3302973
- 发表时间:2007
- 期刊:
- 影响因子:5.1
- 作者:Tseng,J-C;Zheng,Y;Yee,H;Levy,DE;Meruelo,D
- 通讯作者:Meruelo,D
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David E Levy其他文献
RIGging an antiviral defense—it's in the CARDs
操纵抗病毒防御——这在 CARD 中。
- DOI:
10.1038/ni0704-699 - 发表时间:
2004-07-01 - 期刊:
- 影响因子:27.600
- 作者:
David E Levy;Isabelle J Marié - 通讯作者:
Isabelle J Marié
David E Levy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David E Levy', 18)}}的其他基金
A chikungunya Viral Replicon as a Platform for Antiviral Therapeutics
基孔肯雅病毒复制子作为抗病毒治疗的平台
- 批准号:
8789899 - 财政年份:2014
- 资助金额:
$ 61.52万 - 项目类别:
Acquisition of an X-Rad 320 Biological Irradiator
购买 X-Rad 320 生物辐照器
- 批准号:
8703903 - 财政年份:2014
- 资助金额:
$ 61.52万 - 项目类别:
Training Program in Molecular Oncology and Immunology
分子肿瘤学和免疫学培训计划
- 批准号:
8761272 - 财政年份:2013
- 资助金额:
$ 61.52万 - 项目类别:
A chikungunya Viral Replicon as a Platform for Antiviral Therapeutics
基孔肯雅病毒复制子作为抗病毒治疗的平台
- 批准号:
8302538 - 财政年份:2011
- 资助金额:
$ 61.52万 - 项目类别:
Genetic Analysis of Signaling Components in Innate Immunity
先天免疫信号成分的遗传分析
- 批准号:
7670122 - 财政年份:2009
- 资助金额:
$ 61.52万 - 项目类别:
NPM ALK mediated transformation of T lymphocytes
NPM ALK 介导的 T 淋巴细胞转化
- 批准号:
6991316 - 财政年份:2001
- 资助金额:
$ 61.52万 - 项目类别:
NPM ALK mediated transformation of T lymphocytes
NPM ALK 介导的 T 淋巴细胞转化
- 批准号:
7197729 - 财政年份:2001
- 资助金额:
$ 61.52万 - 项目类别:
FUNCTION OF IRF7 IN RESPONSE TO VIRUS INFECTION
IRF7 应对病毒感染的功能
- 批准号:
6196084 - 财政年份:2000
- 资助金额:
$ 61.52万 - 项目类别: